Symbols / SONN
SONN Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | 2025-08-13 16:00 | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
No analyst ratings or price targets available.
- Hyperliquid Strategies (Nasdaq: PURR) to Begin Trading December 3 After Sonnet Deal - Stock Titan ue, 02 Dec 2025 08
- Sonnet BioTherapeutics Stockholders Approve Business Combination with Hyperliquid Strategies Inc and Rorschach I LLC - Quiver Quantitative ue, 02 Dec 2025 08
- With Sonnet BioTherapeutics Stock Sliding, Have You Assessed The Risk? - Trefis Mon, 22 Dec 2025 08
- SONN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Sonnet BioTherapeutics, Inc. Is Fair to Shareholders - Business Wire Mon, 14 Jul 2025 07
- CGTX, RVPH, SHOT, SONN, AKTX Rally After-Hours On Clinical Updates And Fed Rate Cut Momentum - Nasdaq hu, 18 Sep 2025 07
- Sonnet BioTherapeutics Holdings, Inc. (SONN) Stock: Shareholders Approve Hyperliquid Merger, Setting Stage for $1B HYPE Treasury - CoinCentral ue, 02 Dec 2025 08
- Massive deal sends biotech stock rallying 367% - Yahoo Finance Mon, 14 Jul 2025 07
- Sonnet BioTherapeutics Stock Jumps 82% After Deal With Rorschach I: Retail Stays Exuberant - Stocktwits Mon, 14 Jul 2025 19
- Sonnet BioTherapeutics (SONN) Stockholders Approve Business Comb - GuruFocus ue, 02 Dec 2025 08
- Sonnet BioTherapeutics stock soars after $888 million crypto deal - Investing.com Mon, 14 Jul 2025 07
- Sonnet BioTherapeutics Shares Surge 290% Following $888 Million Crypto Merger - MSN Mon, 14 Jul 2025 07
- Sonnet BioTherapeutics Merges with Hyperliquid Strategies - TipRanks Wed, 03 Dec 2025 08
- This Cancer Biotech Company Is Making a Big Bet on the HYPE Crypto. Should You Buy Its Stock Here? - Barchart.com Mon, 04 Aug 2025 07
- Sonnet BioTherapeutics Appoints Interim CEO Raghu Rao - The Globe and Mail Sat, 02 Aug 2025 07
- $SONN Earnings Preview: Recent $SONN Insider Trading, Hedge Fund Activity, and More | SONN Stock News - Quiver Quantitative Sat, 13 Dec 2025 08
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for SONN
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|